9 Einträge gefunden

1. Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

   1. Wei, Andrew H
   2. Strickland, Stephen A
   3. Hou, Jing-Zhou
   4. Fiedler, Walter
   5. Lin, Tara L
   6. Walter, Roland B
   7. Enjeti, Anoop

   2019 - Forschungsinformationssystem des UKE
2. The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

   1. Velthaus, Arne
   2. Cornils, Kerstin
   3. Hennigs, Jan K
   4. Grüb, Saskia
   5. Stamm, Hauke
   6. Wicklein, Daniel
   7. Bokemeyer, Carsten

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer

   1. Stamm, Hauke
   2. Oliveira-Ferrer, Leticia
   3. Grossjohann, Eva-Maria
   4. Muschhammer, Jana
   5. Thaden, Vanessa
   6. Brauneck, Franziska
   7. Kischel, Roman

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study

   1. Hütter-Krönke, Marie Luise
   2. Fiedler, Walter
   3. Kündgen, Andrea
   4. Krauter, Jürgen
   5. von Lilienfeld-Toal, Marie
   6. Döhner, Hartmut
   7. Schlenk, Richard

   2019 - Forschungsinformationssystem des UKE
5. AML: Klinische Bedeutung von Spleißvarianten und Spleiß-assoziierten Genmutationen

   1. Janning, Melanie
   2. Fiedler, Walter

   2019 - Forschungsinformationssystem des UKE
6. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

   1. Cortes, Jorge E
   2. Heidel, Florian H
   3. Hellmann, Andrzej
   4. Fiedler, Walter
   5. Smith, B Douglas
   6. Robak, Tadeusz
   7. Montesinos, Pau

   2019 - Forschungsinformationssystem des UKE
7. Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial

   1. Bixby, Dale
   2. Noppeney, Richard
   3. Lin, Tara L
   4. Cortes, Jorge
   5. Krauter, Jürgen
   6. Yee, Karen
   7. Medeiros, Bruno C

   2019 - Forschungsinformationssystem des UKE
8. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

   1. Döhner, Hartmut
   2. Müller-Tidow, Carsten
   3. Lübbert, Michael
   4. Fiedler, Walter
   5. Krämer, Alwin
   6. Westermann, Jörg
   7. Bug, Gesine

   2019 - Forschungsinformationssystem des UKE
9. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

   1. Schlenk, Richard F
   2. Weber, Daniela
   3. Fiedler, Walter
   4. Salih, Helmut R
   5. Wulf, Gerald
   6. Salwender, Hans
   7. Schroeder, Thomas

   2019 - Forschungsinformationssystem des UKE